- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02371954
Exercise to Prevent Depression and Anxiety in Older Hispanics
6. September 2018 aktualisiert von: Daniel Enrique Jimenez, University of Miami
The study is a randomized pilot trial of a health promotion intervention in the prevention of anxiety and depression in older Hispanics.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Eligible participants will be randomized to either the Happy Older Latinos are Active (HOLA) intervention or a psychoeducation condition.
Participants randomized to HOLA will participate in a group exercise, 3 times a week, for 16 weeks.
The exercise is a moderate intensity walk at a centrally located park in Miami-Dade county and will last for an hour (10 minute warmup/stretching, 30 minute walk, 5 minute cool down).
Groups will consist of 6 participants and be led by a community health worker.
During the cool down phase, participants will plan a pleasant event to be done in between sessions.
Participants randomized to the psychoeducation component will receive a fotonovela and will meet once a month after they receive the fotonovela to discuss their thoughts on the materials they received.
These discussion groups will last one hour and will consist of 10 participants.
A total of 60 participants will be randomized (30 to HOLA, 30 to fotonovela).
Assessments will be conducted at baseline, post intervention, 6 months post-intervention, and 12 months post-intervention.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
60
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Florida
-
Miami, Florida, Vereinigte Staaten, 33136
- Jackson Memorial Mental Health Hospital
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
60 Jahre und älter (Erwachsene, Älterer Erwachsener)
Akzeptiert gesunde Freiwillige
Ja
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Hispanic (self-identified);
- Age 60+;
- Minor depression as defined by a primary DSM-IV Axis I diagnosis of minor depressive disorder or subthreshold depression defined as a score ≥ 3 on the Patient Health Questionnaire (PHQ-2), OR subthreshold anxiety as defined as a score ≥ 3 on the Generalized Anxiety Disorder-2 scale (GAD-2);
- Absence of episodes of major depression and anxiety disorders for past 12 months (as determined by the MINI);
- Voluntary informed consent for participation in the study by the participant or by the participant's legally designated guardian or conservator;
- Medical clearance for participation in an exercise program by a physician, physician's assistant, or nurse practitioner;
- Expect to be resident in Miami for the subsequent 12 months.
Exclusion Criteria:
- Currently residing in a nursing or group home;
- A terminal physical illness expected to result in the death within one year;
- A diagnosis of dementia, co-morbid diagnosis of dementia, or significant cognitive impairment as indicated by an MMSE score <24;
- Presence of any axis 1 psychiatric disorder or substance abuse during preceding 12 months;
- History of psychiatric disorders other than non-psychotic unipolar major depression or anxiety disorder;
- High suicide risk, i.e., intent or plan to attempt suicide in the near future (a response of "yes" to questions 3, 4, and/or 5 on the Paykel Questionnaire);
- Participants taking cognitive enhancing medication or psychotropic medications (e.g. antidepressants);
- unable to complete 400 m walk test in less than 15 min;
- if participant heart rate exceeded 170 beats per minute OR systolic blood pressure exceeds 180 during 400 m walk test;
- chest or leg pain, dyspnea, dizziness, feeling faint, or other significant symptoms while completing 400 m walk test;
(i) acute or severe medical illness that would prevent participants from walking at a moderate pace for 45 minutes, three times a week.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Health Promotion
Happy Older Latinos are Active (HOLA) is multicomponent health promotion intervention led by a community health worker (CHW).
First component is a social and physical activation session.
Participants meet individually with CHW for 30 minutes once at week 1, then again at week 8 (the midway point).
Second component is a moderate intensity group walk.
Groups will consist of 6 participants and will meet for one hour, 3 times a week, for 16 weeks.
Third component is pleasant events scheduling during cool down phase of the group walk.
|
Health promotion intervention desgined to prevent anxiety and depression in at risk older Hispanics
Andere Namen:
|
|
Aktiver Komparator: Psychoeducation
Participants will be given a fotonovela and will meet once a month after they receive the fotonovela to discuss their thoughts on the materials they received.
These discussion groups will last one hour and will consist of 10 participants.
|
Comic book style informational booklet designed for people with low literacy to educate them on mental illness.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Prevention of major depression, generalized anxiety, and social anxiety as measured the Mini International Neuropsychiatric Interview
Zeitfenster: change from baseline at 16 months
|
I will be using the Mini International Neuropsychiatric Interview to test whether the HOLA intervention was successful in preventing participants from getting major depressive disorder, generalized anxiety disorder, and social anxiety disorder.
|
change from baseline at 16 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Physical functioning as measured by the World Health Organization Disability Assessment Schedule 2.0 (WHO-DAS 2)
Zeitfenster: change from baseline at 16 months
|
I will be measuring the effect the HOLA intervention has on the scores of the Getting Around, Life Activities, and Self-Care subscales of the WHO-DAS 2.0
|
change from baseline at 16 months
|
|
Social functioningas measured by the World Health Organization Disability Assessment Schedule 2.0 (WHO-DAS 2)
Zeitfenster: change from baseline at 16 months
|
I will be measuring the effect the HOLA intervention has on the scores of the Getting Along with People and Participation in Life subscales of the WHO-DAS 2.0
|
change from baseline at 16 months
|
|
Self-efficacy as measured by the General Self-Efficacy Scale
Zeitfenster: change from baseline at 16 months
|
I will be measuring the effect the HOLA intervention has on total scores of the General-Self Efficacy Scale.
|
change from baseline at 16 months
|
|
Sleep quality as measured by the Pittsburgh Sleep Quality Index
Zeitfenster: change from baseline at 16 months
|
I will be measuring the effect the HOLA intervention has on the total scores of the Pittsburgh Sleep Quality Index
|
change from baseline at 16 months
|
|
Change in depression symptom severity as measured by the Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR).
Zeitfenster: change from baseline at 16 months
|
I will be measuring the effect the HOLA intervention has on the total scores of the QIDS-SR
|
change from baseline at 16 months
|
|
Change in anxiety symptom severity as measured by the Beck Anxiety Inventory (BAI)
Zeitfenster: change from baseline at 16 months
|
I will be measuring the effect the HOLA intervention has on the total scores of the BAI
|
change from baseline at 16 months
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Ermittler
- Hauptermittler: Daniel E Jimenez, Ph.D., University of Miami
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
1. September 2013
Primärer Abschluss (Tatsächlich)
1. August 2018
Studienabschluss (Tatsächlich)
1. August 2018
Studienanmeldedaten
Zuerst eingereicht
21. Januar 2015
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
20. Februar 2015
Zuerst gepostet (Schätzen)
26. Februar 2015
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
7. September 2018
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
6. September 2018
Zuletzt verifiziert
1. September 2018
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 20140607
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .